Earnings call transcript: Everest Medicines posts H1 profit inflection, shares sink 13%
Covered in this story
What has happened since
- Everest Group is up 9.5% since this was published, 67 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $EG yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Everest Group →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.